Christine Sumiko Tsang, NP
Nurse Practitioner · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 23 years
- University of California, San Francisco School of Medicine, 2003
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Eden Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Christine Sumiko Tsang’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C14706 · Cancelled
Licence status: Cancelled · since 1953 · Northwestern University Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$24,000
Medicare paid this office $24,000 for 79 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 61 | $11,544 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,088 | $132 |
| Sarscov2 vac 50 mcg/0.5ml im | 12 | $1,921 | $148 |
| Admn sarscov2 vacc 1 dose | 12 | $671 | $52 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 25 | $440 | $12 |
Who their Medicare patients are
79 Original Medicare patients in 2024. Average age 74 · Women 72% · Also on Medicaid 32% · Health risk score 1.33. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 73% · Diabetes 30% · Chronic kidney disease 20% · Depression 19% · Coronary heart disease 18% · COPD 16% · Cancer 14%.
The office billed $79,999, Medicare allowed $29,481 and paid $24,000; for 295 services of 24 kinds; $5,324 of it was for drugs given in the office and $18,676 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 79 | 295 | 74 | 1.33 | $79,999 | $24,000 |
| 2023 | 72 | 228 | 74 | 1.23 | $66,163 | $19,014 |
| 2022 | 90 | 253 | 73 | 1.26 | $74,212 | $21,082 |
| 2021 | 115 | 342 | 74 | 1.06 | $93,092 | $27,015 |
| 2020 | 116 | 1,722 | 71 | 1.34 | $75,859 | $21,537 |
| 2019 | 111 | 397 | 72 | 1.20 | $93,292 | $25,198 |
| 2018 | 158 | 486 | 71 | 1.28 | $92,861 | $25,717 |
| 2017 | 114 | 331 | 70 | 1.19 | $62,731 | $18,103 |
| 2016 | 207 | 436 | 73 | 1.12 | $96,638 | $23,756 |
| 2015 | 211 | 578 | 75 | 1.10 | $112,901 | $29,486 |
| 2014 | 238 | 507 | 75 | 0.99 | $106,227 | $23,239 |
| 2013 | 231 | 534 | 75 | 1.07 | $103,333 | $22,104 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 61 | $11,034 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,794 | $133 |
2022: 3 services
| Return visit (30+ min) | 71 | $11,418 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,710 | $133 |
| Administration of influenza virus vaccine | 11 | $342 | $31 |
2021: 5 services
| Return visit (30+ min) | 87 | $15,940 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $4,312 | $135 |
| Short return visit (20+ min) | 30 | $1,914 | $56 |
| Influenza vaccine split virus, preservative free | 19 | $1,231 | $65 |
| Administration of influenza virus vaccine | 20 | $368 | $18 |
2020: 6 services
| Return visit (30+ min) | 58 | $8,206 | $73 |
| Short return visit (20+ min) | 37 | $2,600 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,160 | $120 |
| New patient visit (30+ min) | 20 | $2,146 | $107 |
| Influenza vaccine split virus, preservative free | 17 | $1,023 | $60 |
| Administration of influenza virus vaccine | 18 | $369 | $21 |
2019: 10 services
| Return visit (30+ min) | 84 | $13,074 | $75 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $2,967 | $119 |
| Pneumococcal vaccine, 13-valent | 11 | $2,281 | $207 |
| Pneumococcal vaccine, 23-valent | 12 | $1,343 | $112 |
| Short return visit (20+ min) | 29 | $1,238 | $38 |
| Influenza vaccine split virus, preservative free | 22 | $1,168 | $53 |
| New patient visit (45+ min) | 11 | $1,110 | $101 |
| Administration of influenza virus vaccine | 24 | $484 | $20 |
| Administration of pneumococcal vaccine | 23 | $464 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $155 | $13 |
2018: 9 services
| Return visit (30+ min) | 86 | $9,657 | $73 |
| Short return visit (20+ min) | 78 | $5,037 | $48 |
| Pneumococcal vaccine, 13-valent | 11 | $2,162 | $197 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,528 | $118 |
| Pneumococcal vaccine, 23-valent | 14 | $1,478 | $106 |
| Influenza vaccine split virus, preservative free | 30 | $1,309 | $44 |
| Administration of influenza virus vaccine | 39 | $986 | $25 |
| Administration of pneumococcal vaccine | 25 | $632 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $166 | $9 |
2017: 8 services
| Return visit (30+ min) | 58 | $5,541 | $78 |
| Short return visit (20+ min) | 47 | $2,646 | $46 |
| New patient visit (45+ min) | 23 | $2,128 | $93 |
| Pneumococcal vaccine, 13-valent | 11 | $2,077 | $189 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,256 | $114 |
| Influenza vaccine split virus, preservative free | 25 | $1,103 | $44 |
| Administration of influenza virus vaccine | 29 | $902 | $31 |
| Administration of pneumococcal vaccine | 12 | $373 | $31 |
2016: 10 services
| Return visit (30+ min) | 94 | $7,665 | $66 |
| Short return visit (20+ min) | 100 | $4,971 | $40 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $2,901 | $112 |
| Pneumococcal vaccine, 13-valent | 16 | $2,793 | $175 |
| New patient visit (45+ min) | 14 | $1,468 | $105 |
| Administration of pneumococcal vaccine | 21 | $628 | $30 |
| Administration of influenza virus vaccine | 15 | $509 | $30 |
| Influenza vaccine split virus, preservative free | 12 | $439 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $185 | $10 |
| Urinalysis, manual test | 11 | $38 | $3 |
2015: 9 services
| Short return visit (20+ min) | 133 | $8,930 | $47 |
| Return visit (30+ min) | 81 | $8,567 | $71 |
| Pneumococcal vaccine, 13-valent | 25 | $4,054 | $162 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,571 | $112 |
| Influenza vaccine split virus, preservative free | 37 | $1,314 | $36 |
| Administration of influenza virus vaccine | 39 | $1,171 | $30 |
| Administration of pneumococcal vaccine | 29 | $899 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $292 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $170 | $15 |
2014: 8 services
| Return visit (30+ min) | 94 | $7,801 | $68 |
| Short return visit (20+ min) | 138 | $7,454 | $44 |
| Influenza vaccine split virus, preservative free | 37 | $1,208 | $33 |
| Administration of influenza virus vaccine | 39 | $1,192 | $30 |
| New patient visit (30+ min) | 13 | $821 | $63 |
| Short return visit | 13 | $384 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $259 | $13 |
| Urinalysis, manual test | 14 | $48 | $3 |
2013: 9 services
| Short return visit (20+ min) | 157 | $9,555 | $44 |
| Return visit (30+ min) | 87 | $7,807 | $68 |
| Administration of influenza virus vaccine | 17 | $519 | $31 |
| Influenza vaccine split virus, preservative free | 16 | $494 | $31 |
| Short return visit | 11 | $407 | $34 |
| Administration of vaccine | 17 | $314 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $243 | $11 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $209 | $16 |
| Urinalysis, manual test | 25 | $94 | $3 |
Drugs they prescribed that Part D paid
$96,586
Pharmacies billed $96,586 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (28 of 1,099) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
975 generic and fewer than 11 brand-name prescriptions · $96,586 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 18 | $22,549 | $1,253 |
| Eliquis | 13 | $10,932 | $841 |
| Atorvastatin | 77 | $1,072 | $14 |
| Albuterol Sulfate Hfa | 25 | $953 | $38 |
| Hydrocodone-Acetaminophen | 25 | $728 | $29 |
See all 27 drugs
| Ozempic | 18 | $22,549 | $1,253 |
| Eliquis | 13 | $10,932 | $841 |
| Atorvastatin | 77 | $1,072 | $14 |
| Albuterol Sulfate Hfa | 25 | $953 | $38 |
| Hydrocodone-Acetaminophen | 25 | $728 | $29 |
| Metoprolol | 49 | $669 | $14 |
| Rosuvastatin | 18 | $530 | $29 |
| Gabapentin | 27 | $489 | $18 |
| Losartan | 42 | $471 | $11 |
| Amlodipine Besylate | 76 | $471 | $6 |
| Metformin Hcl Er | 22 | $427 | $19 |
| Levothyroxine | 32 | $374 | $12 |
| Pantoprazole | 21 | $364 | $17 |
| Montelukast | 14 | $341 | $24 |
| Glipizide Er | 12 | $241 | $20 |
| Lisinopril | 48 | $238 | $5 |
| Nystatin | 17 | $232 | $14 |
| Famotidine | 13 | $141 | $11 |
| Meloxicam | 16 | $126 | $8 |
| Fluoxetine | 16 | $119 | $7 |
| Omeprazole | 23 | $112 | $5 |
| Zolpidem | 19 | $108 | $6 |
| Sertraline | 19 | $106 | $6 |
| Lorazepam | 18 | $76 | $4 |
| Simvastatin | 38 | $67 | $2 |
| Hydrochlorothiazide | 18 | $40 | $2 |
| Metformin | 13 | $34 | $3 |
Year by year
| 2024 | 1,099 | 110 | 3% (28) | None | $96,586 |
| 2023 | 1,024 | 113 | 4% (43) | None | $121,706 |
| 2022 | 1,134 | 148 | 6% (67) | 10% | $105,815 |
| 2021 | 1,212 | 187 | 5% (57) | None | $94,159 |
| 2020 | 1,242 | 166 | 5% (66) | None | $89,027 |
| 2019 | 1,214 | 130 | 7% (90) | None | $83,367 |
| 2018 | 891 | 143 | 6% (57) | None | $80,855 |
| 2017 | 826 | 153 | 4% (30) | None | $66,311 |
| 2016 | 1,407 | 248 | 5% (70) | None | $92,272 |
| 2015 | 1,318 | 258 | 3% (41) | None | $74,285 |
| 2014 | 1,530 | 316 | 3% (42) | None | $110,028 |
| 2013 | 1,111 | 273 | 3% (36) | None | $51,614 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Trulicity | 14 | $27,888 | $1,992 |
| Ozempic | 17 | $24,575 | $1,446 |
| Atorvastatin | 73 | $1,737 | $24 |
| Rosuvastatin | 17 | $1,198 | $70 |
| Metoprolol | 47 | $996 | $21 |
| Amlodipine Besylate | 61 | $829 | $14 |
| Metformin Hcl Er | 21 | $773 | $37 |
| Levothyroxine | 35 | $719 | $21 |
| Hydrocodone-Acetaminophen | 26 | $713 | $27 |
| Lisinopril | 53 | $624 | $12 |
| Losartan | 34 | $501 | $15 |
| Omeprazole | 20 | $470 | $23 |
| Simvastatin | 29 | $467 | $16 |
| Gabapentin | 19 | $460 | $24 |
| Bupropion | 12 | $406 | $34 |
| Carvedilol | 14 | $384 | $27 |
| Pravastatin | 14 | $320 | $23 |
| Pantoprazole | 18 | $274 | $15 |
| Glipizide Er | 13 | $254 | $20 |
| Triamcinolone Acetonide | 13 | $173 | $13 |
| Ibuprofen | 15 | $140 | $9 |
| Metformin | 13 | $134 | $10 |
| Lorazepam | 13 | $90 | $7 |
| Fluoxetine | 11 | $51 | $5 |
| Hydrochlorothiazide | 18 | $46 | $3 |
2022: 29 drugs
| Trulicity | 14 | $18,919 | $1,351 |
| Xtampza Er | 11 | $6,149 | $559 |
| Combivent Respimat | 12 | $5,951 | $496 |
| Atorvastatin | 107 | $1,465 | $14 |
| Metoprolol | 60 | $1,158 | $19 |
| Albuterol Sulfate Hfa | 13 | $1,095 | $84 |
| Hydrocodone-Acetaminophen | 41 | $1,089 | $27 |
| Levothyroxine | 43 | $1,018 | $24 |
| Amlodipine Besylate | 62 | $880 | $14 |
| Mirtazapine | 14 | $735 | $53 |
| Lisinopril | 58 | $600 | $10 |
| Hydralazine | 11 | $551 | $50 |
| Rosuvastatin | 19 | $542 | $29 |
| Bupropion | 17 | $516 | $30 |
| Omeprazole | 26 | $484 | $19 |
| Simvastatin | 29 | $438 | $15 |
| Oxycodone-Acetaminophen | 13 | $425 | $33 |
| Pantoprazole | 23 | $411 | $18 |
| Ondansetron | 14 | $381 | $27 |
| Carvedilol | 13 | $362 | $28 |
| Losartan | 32 | $302 | $9 |
| Metformin Hcl Er | 17 | $268 | $16 |
| Pravastatin | 23 | $265 | $12 |
| Clopidogrel | 16 | $176 | $11 |
| Furosemide | 15 | $117 | $8 |
| Sertraline | 13 | $116 | $9 |
| Famotidine | 11 | $114 | $10 |
| Ibuprofen | 12 | $80 | $7 |
| Lorazepam | 14 | $33 | $2 |
2021: 27 drugs
| Trulicity | 13 | $15,817 | $1,217 |
| Eliquis | 11 | $15,316 | $1,392 |
| Metoprolol | 53 | $1,416 | $27 |
| Atorvastatin | 103 | $1,270 | $12 |
| Albuterol Sulfate Hfa | 22 | $1,175 | $53 |
| Hydrocodone-Acetaminophen | 39 | $814 | $21 |
| Losartan | 40 | $768 | $19 |
| Levothyroxine | 36 | $742 | $21 |
| Amlodipine Besylate | 64 | $662 | $10 |
| Omeprazole | 24 | $462 | $19 |
| Rosuvastatin | 13 | $455 | $35 |
| Simvastatin | 41 | $453 | $11 |
| Lisinopril | 64 | $450 | $7 |
| Amlodipine Besylate-Benazepril | 12 | $385 | $32 |
| Fluticasone Propionate | 12 | $349 | $29 |
| Hydralazine | 11 | $295 | $27 |
| Pantoprazole | 19 | $269 | $14 |
| Bupropion | 15 | $208 | $14 |
| Pravastatin | 20 | $192 | $10 |
| Fluoxetine | 12 | $137 | $11 |
| Hydrochlorothiazide | 23 | $117 | $5 |
| Atenolol | 12 | $95 | $8 |
| Clopidogrel | 18 | $91 | $5 |
| Metformin Hcl Er | 13 | $82 | $6 |
| Glimepiride | 12 | $62 | $5 |
| Zolpidem | 14 | $44 | $3 |
| Lorazepam | 12 | $38 | $3 |
2020: 33 drugs
| Trulicity | 14 | $21,479 | $1,534 |
| Amitiza | 13 | $4,664 | $359 |
| Metoprolol | 46 | $1,486 | $32 |
| Atorvastatin | 89 | $1,284 | $14 |
| Losartan | 49 | $1,134 | $23 |
| Ventolin Hfa | 16 | $1,094 | $68 |
| Potassium Chloride | 13 | $967 | $74 |
| Levothyroxine | 41 | $792 | $19 |
| Lisinopril | 62 | $694 | $11 |
| Midodrine | 13 | $669 | $51 |
| Hydrocodone-Acetaminophen | 46 | $661 | $14 |
| Simvastatin | 42 | $500 | $12 |
| Amlodipine Besylate | 45 | $477 | $11 |
| Baclofen | 14 | $369 | $26 |
| Oxybutynin Chloride Er | 17 | $316 | $19 |
| Allopurinol | 12 | $303 | $25 |
| Sertraline | 28 | $300 | $11 |
| Rizatriptan | 13 | $270 | $21 |
| Pantoprazole | 16 | $269 | $17 |
| Omeprazole | 14 | $262 | $19 |
| Lovastatin | 16 | $260 | $16 |
| Fluoxetine | 15 | $255 | $17 |
| Gabapentin | 13 | $243 | $19 |
| Amlodipine Besylate-Benazepril | 11 | $233 | $21 |
| Atenolol | 16 | $192 | $12 |
| Clopidogrel | 17 | $171 | $10 |
| Pravastatin | 19 | $133 | $7 |
| Metformin Hcl Er | 13 | $124 | $10 |
| Hydrochlorothiazide | 18 | $106 | $6 |
| Metformin | 24 | $106 | $4 |
| Zolpidem | 22 | $100 | $5 |
| Alprazolam | 14 | $32 | $2 |
| Glimepiride | 12 | $22 | $2 |
2019: 25 drugs
| Metoprolol | 30 | $1,268 | $42 |
| Hydrocodone-Acetaminophen | 63 | $1,237 | $20 |
| Ventolin Hfa | 13 | $1,205 | $93 |
| Atorvastatin | 62 | $1,191 | $19 |
| Lisinopril | 59 | $796 | $13 |
| Levothyroxine | 32 | $728 | $23 |
| Omeprazole | 23 | $624 | $27 |
| Sertraline | 37 | $609 | $16 |
| Losartan | 34 | $575 | $17 |
| Simvastatin | 53 | $538 | $10 |
| Pantoprazole | 16 | $385 | $24 |
| Amlodipine Besylate | 46 | $380 | $8 |
| Metformin Hcl Er | 18 | $336 | $19 |
| Gabapentin | 19 | $305 | $16 |
| Zolpidem | 27 | $289 | $11 |
| Metformin | 25 | $238 | $10 |
| Alendronate | 13 | $181 | $14 |
| Hydrochlorothiazide | 29 | $181 | $6 |
| Ondansetron | 15 | $143 | $10 |
| Alprazolam | 19 | $136 | $7 |
| Meloxicam | 15 | $124 | $8 |
| Glipizide | 11 | $103 | $9 |
| Triamcinolone Acetonide | 14 | $99 | $7 |
| Furosemide | 13 | $96 | $7 |
| Lorazepam | 11 | $69 | $6 |
2018: 19 drugs
| Ventolin Hfa | 20 | $1,741 | $87 |
| Metoprolol | 29 | $1,680 | $58 |
| Proctozone-Hc | 16 | $1,166 | $73 |
| Atorvastatin | 43 | $1,092 | $25 |
| Hydrocodone-Acetaminophen | 45 | $876 | $19 |
| Levothyroxine | 22 | $554 | $25 |
| Lisinopril | 37 | $432 | $12 |
| Amlodipine Besylate | 45 | $371 | $8 |
| Fluticasone Propionate | 16 | $327 | $20 |
| Losartan | 25 | $318 | $13 |
| Gabapentin | 21 | $310 | $15 |
| Sertraline | 24 | $302 | $13 |
| Simvastatin | 27 | $248 | $9 |
| Allopurinol | 12 | $185 | $15 |
| Metformin | 16 | $165 | $10 |
| Alendronate | 12 | $154 | $13 |
| Omeprazole | 13 | $118 | $9 |
| Hydrochlorothiazide | 11 | $81 | $7 |
| Furosemide | 16 | $54 | $3 |
2017: 24 drugs
| Zetia | 12 | $4,401 | $367 |
| Flovent Hfa | 12 | $4,258 | $355 |
| Pradaxa | 11 | $4,162 | $378 |
| Proair Hfa | 19 | $1,180 | $62 |
| Atorvastatin | 48 | $1,067 | $22 |
| Metoprolol | 16 | $930 | $58 |
| Ketoconazole | 14 | $536 | $38 |
| Nifedipine Er | 11 | $417 | $38 |
| Levothyroxine | 15 | $411 | $27 |
| Hydrocodone-Acetaminophen | 25 | $274 | $11 |
| Amlodipine Besylate | 41 | $260 | $6 |
| Tamsulosin | 12 | $259 | $22 |
| Lisinopril | 36 | $247 | $7 |
| Omeprazole | 16 | $231 | $14 |
| Losartan | 25 | $229 | $9 |
| Metformin | 30 | $218 | $7 |
| Montelukast | 20 | $196 | $10 |
| Gabapentin | 13 | $161 | $12 |
| Sertraline | 11 | $150 | $14 |
| Simvastatin | 28 | $144 | $5 |
| Mirtazapine | 12 | $130 | $11 |
| Glipizide | 15 | $111 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $68 | $5 |
| Furosemide | 12 | $55 | $5 |
2016: 39 drugs
| Advair Diskus | 27 | $13,048 | $483 |
| Flovent Hfa | 13 | $3,739 | $288 |
| Combivent Respimat | 11 | $3,500 | $318 |
| Demeclocycline | 12 | $2,398 | $200 |
| Morphine Sulfate Er | 20 | $1,860 | $93 |
| Levothyroxine | 54 | $1,587 | $29 |
| Atorvastatin | 72 | $1,557 | $22 |
| Metoprolol | 25 | $808 | $32 |
| Valsartan | 17 | $738 | $43 |
| Potassium Chloride | 19 | $664 | $35 |
| Hydrocodone-Acetaminophen | 27 | $644 | $24 |
| Ventolin Hfa | 12 | $620 | $52 |
| Fluoxetine | 24 | $549 | $23 |
| Nortriptyline | 11 | $498 | $45 |
| Lisinopril | 64 | $488 | $8 |
| Tamsulosin | 16 | $461 | $29 |
| Losartan | 29 | $455 | $16 |
| Simvastatin | 44 | $423 | $10 |
| Triamterene-Hydrochlorothiazid | 37 | $371 | $10 |
| Amlodipine Besylate | 50 | $353 | $7 |
| Gabapentin | 29 | $319 | $11 |
| Warfarin | 11 | $310 | $28 |
| Omeprazole | 23 | $288 | $13 |
| Glipizide | 20 | $242 | $12 |
| Metformin | 39 | $242 | $6 |
| Pravastatin | 17 | $240 | $14 |
| Hydrochlorothiazide | 50 | $225 | $4 |
| Pantoprazole | 20 | $206 | $10 |
| Mirtazapine | 16 | $194 | $12 |
| Lovastatin | 21 | $193 | $9 |
| Allopurinol | 14 | $184 | $13 |
| Carvedilol | 17 | $175 | $10 |
| Atenolol | 36 | $170 | $5 |
| Venlafaxine Hcl Er | 15 | $150 | $10 |
| Azithromycin | 18 | $142 | $8 |
| Furosemide | 17 | $142 | $8 |
| Ciprofloxacin | 12 | $131 | $11 |
| Montelukast | 16 | $125 | $8 |
| Sertraline | 12 | $67 | $6 |
2015: 35 drugs
| Advair Diskus | 27 | $12,638 | $468 |
| Lantus | 12 | $3,075 | $256 |
| Asmanex | 11 | $2,137 | $194 |
| Proair Hfa | 39 | $2,082 | $53 |
| Valsartan | 28 | $1,734 | $62 |
| Atorvastatin | 76 | $1,343 | $18 |
| Levothyroxine | 48 | $1,326 | $28 |
| Proventil Hfa | 15 | $1,003 | $67 |
| Potassium Chloride | 47 | $751 | $16 |
| Dilantin | 11 | $734 | $67 |
| Metoprolol | 18 | $644 | $36 |
| Fluticasone Propionate | 33 | $599 | $18 |
| Pyridostigmine | 12 | $565 | $47 |
| Warfarin | 28 | $473 | $17 |
| Hydrocodone-Acetaminophen | 22 | $453 | $21 |
| Lactulose | 14 | $451 | $32 |
| Chlorthalidone | 13 | $380 | $29 |
| Lisinopril | 48 | $342 | $7 |
| Allopurinol | 21 | $337 | $16 |
| Venlafaxine Hcl Er | 26 | $281 | $11 |
| Triamterene-Hydrochlorothiazid | 24 | $274 | $11 |
| Lovastatin | 11 | $193 | $18 |
| Hydrochlorothiazide | 22 | $191 | $9 |
| Atenolol | 29 | $168 | $6 |
| Amlodipine Besylate | 30 | $160 | $5 |
| Gabapentin | 11 | $150 | $14 |
| Metformin | 34 | $150 | $4 |
| Furosemide | 27 | $148 | $5 |
| Fluoxetine | 14 | $148 | $11 |
| Simvastatin | 21 | $123 | $6 |
| Glipizide | 19 | $111 | $6 |
| Azithromycin | 13 | $83 | $6 |
| Triamcinolone Acetonide | 11 | $80 | $7 |
| Escitalopram | 13 | $73 | $6 |
| Benazepril | 13 | $51 | $4 |
2014: 43 drugs
| Advair Diskus | 22 | $11,450 | $520 |
| Colcrys | 11 | $3,613 | $328 |
| Lantus | 13 | $3,600 | $277 |
| Namenda | 12 | $3,238 | $270 |
| Diovan | 14 | $3,108 | $222 |
| Proair Hfa | 42 | $2,360 | $56 |
| Metoprolol | 32 | $1,567 | $49 |
| Atorvastatin | 48 | $1,416 | $30 |
| Levothyroxine | 64 | $1,315 | $21 |
| Fluticasone Propionate | 34 | $672 | $20 |
| Venlafaxine Hcl Er | 33 | $669 | $20 |
| Doxazosin Mesylate | 12 | $599 | $50 |
| Potassium Chloride | 31 | $555 | $18 |
| Lisinopril | 84 | $510 | $6 |
| Clotrimazole | 12 | $461 | $38 |
| Fluoxetine | 16 | $448 | $28 |
| Metformin | 41 | $439 | $11 |
| Verapamil Er | 11 | $379 | $34 |
| Hydrocodone-Acetaminophen | 30 | $373 | $12 |
| Warfarin | 32 | $340 | $11 |
| Omeprazole | 18 | $322 | $18 |
| Simvastatin | 40 | $320 | $8 |
| Losartan | 16 | $297 | $19 |
| Liothyronine | 15 | $289 | $19 |
| Tamsulosin | 17 | $276 | $16 |
| Triamterene-Hydrochlorothiazid | 20 | $247 | $12 |
| Amlodipine Besylate | 28 | $239 | $9 |
| Carvedilol | 13 | $224 | $17 |
| Gabapentin | 22 | $217 | $10 |
| Atenolol | 27 | $216 | $8 |
| Paroxetine | 11 | $211 | $19 |
| Klor-Con 10 | 12 | $209 | $17 |
| Lovastatin | 13 | $201 | $15 |
| Acyclovir | 15 | $192 | $13 |
| Azithromycin | 25 | $192 | $8 |
| Triamcinolone Acetonide | 11 | $190 | $17 |
| Pantoprazole | 14 | $187 | $13 |
| Allopurinol | 28 | $185 | $7 |
| Metoprolol | 21 | $141 | $7 |
| Hydrochlorothiazide | 20 | $119 | $6 |
| Isosorbide Mononitrate Er | 11 | $96 | $9 |
| Furosemide | 23 | $79 | $3 |
| Glipizide | 11 | $27 | $2 |
2013: 25 drugs
| Diovan | 18 | $3,506 | $195 |
| Proair Hfa | 43 | $2,056 | $48 |
| Fluticasone Propionate | 34 | $965 | $28 |
| Metoprolol | 21 | $932 | $44 |
| Omeprazole | 30 | $557 | $19 |
| Lisinopril | 65 | $529 | $8 |
| Levothyroxine | 36 | $514 | $14 |
| Clotrimazole | 13 | $487 | $37 |
| Losartan | 21 | $421 | $20 |
| Metformin | 41 | $382 | $9 |
| Hydrocodone-Acetaminophen | 18 | $315 | $17 |
| Amlodipine Besylate | 24 | $304 | $13 |
| Simvastatin | 32 | $293 | $9 |
| Pravastatin | 11 | $268 | $24 |
| Azithromycin | 26 | $249 | $10 |
| Warfarin | 24 | $234 | $10 |
| Atenolol | 22 | $223 | $10 |
| Potassium Chloride | 14 | $191 | $14 |
| Hydrochlorothiazide | 30 | $190 | $6 |
| Clonazepam | 15 | $151 | $10 |
| Furosemide | 34 | $138 | $4 |
| Acyclovir | 11 | $127 | $12 |
| Allopurinol | 14 | $105 | $8 |
| Metoprolol | 13 | $89 | $7 |
| Ciprofloxacin | 11 | $71 | $6 |
Money from drug and device companies
$37 in 2021
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $37 | 1 payment
|
See the published payment
| Pfizer | Meals · 2021-11-02 | Prevnar 20 | $37 |
Professional record
- NPI
- 1235332370
- Licence
- CA 14706California C14706: Cancelled
- Trained
- University of California, San Francisco School of Medicine, 2003 · 23 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 12 Camino Encinas, Orinda, CA, 94563
- NPI first listed
- 2007-06-06
- NPI last updated
- 2026-02-12
This is when the NPI record was last certified, not a medical board exam.